Table 3.

HRs for abnormal lipid levels predicting risk of biochemical recurrence after radical prostatectomy

Total cholesterolContinuous; ≥ 200 mg/dL
 Unadjusted1.06 (0.97–1.15), P = 0.206
 Adjusteda1.09 (1.01–1.19), P = 0.027
LDLContinuous; ≥ 130 mg/dL
 Unadjusted1.01 (0.90–1.13), P = 0.860
 Adjusteda1.05 (0.94–1.17), P = 0.356
HDLContinuous; < 40 mg/dL
 Unadjusted0.73 (0.51–1.04), P = 0.085
 Adjusteda0.61 (0.41–0.91), P = 0.016
TriglyceridesContinuous; ≥ 150 mg/dL
 Unadjusted1.04 (1.02–1.06), P < 0.001
 Adjusteda1.03 (1.01–1.05), P = 0.004

NOTE: Cells display HR (95% CI), P value.

All HRs are for every 10 mg/dL increase.

  • aHRs are adjusted for age, race, preoperative PSA, year of surgery, BMI, surgical center, postoperative statin use, pathologic Gleason score, positive surgical margins, extracapsular extension, and seminal vesicle invasion.